Physician

Nakul Singh, MD

According to 2025 Medicare claims, Nakul Singh, MD (NPI: 1649776535) practices ophthalmology in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is VITREO-RETINAL MEDICAL GROUP, INC. (NPI: 1114010949; TIN: 942442567) and primary practice location at 95356-9404. Singh is affiliated with the NeueHealth Advantage ACO, LLC (ACO ID: D0151), NeueHealth Premier ACO, LLC (ACO ID: D0181), and NeueHealth Community ACO, LLC (ACO ID: D0324), participating under the REACH model.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 255 traditional Medicare patients, billed 1,862 HCPCS/CPT codes, and received $133,147 in Medicare payments. The top billing code was 67042 (Removal of membrane of retina with removal of internal limiting membrane of retina). Part D data shows 338 prescription claims across 135 beneficiaries totaling $9,226 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 4 records totaling $346. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $617 to $9,226. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$67K$133K2022 Medicare payment: $27,889 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $66,918 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $133,147 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022112217$27,889
2023242536$66,918
20242551,862$133,147

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$30K2018 Drug cost: $617 (USD; Tot_Drug_Cst)2019 Drug cost: $6,438 (USD; Tot_Drug_Cst)2020 Drug cost: $10,840 (USD; Tot_Drug_Cst)2021 Drug cost: $24,933 (USD; Tot_Drug_Cst)2022 Drug cost: $29,635 (USD; Tot_Drug_Cst)2023 Drug cost: $18,798 (USD; Tot_Drug_Cst)2024 Drug cost: $9,226 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181222$617
20194583$6,438
202071154$10,840
2021103257$24,933
2022134344$29,635
2023177524$18,798
2024135338$9,226

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67042Removal of membrane of retina with removal of internal limiting membrane of retina2324$183
92235Exam of retinal blood vessels using a special camera after injection of a dye3535$132
67028Injection of drug into eye6068$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2323$66
92134Imaging of retina144154$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1164,189$4,960
ErythromycinErythromycin Base67651$957
Brimonidine TartrateBrimonidine Tartrate18738$885
Ketorolac TromethamineKetorolac Tromethamine23892$633
OfloxacinOfloxacin42789$413

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$346BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nakul Singh, MD?

Tedicare shows public-source Medicare data for Nakul Singh, MD (NPI 1649776535), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nakul Singh, MD have ACO affiliation data?

Nakul Singh, MD is shown with ACO affiliation data for NeueHealth Advantage ACO, LLC (REACH, ACO ID D0151), NeueHealth Premier ACO, LLC (REACH, ACO ID D0181), and NeueHealth Community ACO, LLC (REACH, ACO ID D0324).

What billing organization is linked to Nakul Singh, MD?

Nakul Singh, MD is linked to VITREO-RETINAL MEDICAL GROUP, INC. (billing NPI 1114010949) in the available physician profile data.

Does Nakul Singh, MD have Open Payments data?

Nakul Singh, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.